Summit Therapeutics (SMMT) Goodwill & Intangibles (2017 - 2026)

Summit Therapeutics (SMMT) has 10 years of Goodwill & Intangibles data on file, last reported at $2.0 million in Q2 2026.

• Quarterly Goodwill & Intangibles fell 3.48% year-over-year to $2.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $2.0 million (down 3.48% YoY) and the FY2025 annual result came in at $2.0 million, up 7.35% from the prior year.
• Goodwill & Intangibles steadied at $2.0 million in Q2 2026, from $2.0 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $11.8 million in Q1 2022 to a low of $1.8 million in Q4 2022.
• A 5-year average of $3.4 million and a median of $1.9 million in 2025 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles plunged 85.51% — and 2024, when it grew 9.76%.
• Tracing SMMT's Goodwill & Intangibles over 5 years: stood at $1.8 million in 2022, then climbed by 5.28% to $1.9 million in 2023, then dropped by 1.53% to $1.9 million in 2024, then grew by 7.35% to $2.0 million in 2025, then retreated by 1.65% to $2.0 million in 2026.
• The last three Goodwill & Intangibles figures came in at $2.0 million (Q2 2026), $2.0 million (Q1 2026), and $2.0 million (Q4 2025), per Business Quant data.